APA

Muraki M., Gose K., Hanada S., Sawaguchi H. & Tohda Y. (20171214). Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?. : Drug delivery.

Chicago

Muraki Masato, Gose Kyuya, Hanada Soichiro, Sawaguchi Hirochiyo and Tohda Yuji. 20171214. Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?. : Drug delivery.

Harvard

Muraki M., Gose K., Hanada S., Sawaguchi H. and Tohda Y. (20171214). Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?. : Drug delivery.

MLA

Muraki Masato, Gose Kyuya, Hanada Soichiro, Sawaguchi Hirochiyo and Tohda Yuji. Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?. : Drug delivery. 20171214.